The best diagnostic platform of 2026
Four platforms worth comparing — Mito Health, Function Health, InsideTracker, and Lifeforce — head-to-head on biomarker breadth, cadence, past-lab integration, physician access, and price. The shortlist for buyers building a serious longevity-medicine diagnostic stack.
Editor's pick: Mito Health
For first-time comprehensive-diagnostics buyers in 2026, Mito Health is the conservative-correct pick. At $359/year for 100+ biomarkers, AI-driven personalized insights, and physician review, it matches Function Health’s product surface at a $140-cheaper annual price. The substantive differentiator is past-lab integration — you can upload historical bloodwork on day one and the AI insights work immediately, rather than waiting a year for the platform to draw its own baseline. Genetics and gut microbiome add-ons round out the scope. Function is the more established ecosystem; Mito is the better entry economics for buyers without prior longitudinal commitment.
Best ecosystem maturity: Function Health ($499/yr) — 110+ biomarkers, 4-year track record, larger community, deeper editorial coverage. The right pick if brand maturity matters more than $140 in annual savings.
Best for action specificity: InsideTracker Ultimate ($589 single test) — 48 biomarkers paired with the strongest “do X” recommendations in the category. The right pick if you want explicit food/exercise/supplement actions rather than raw lab data.
Best for high-touch coaching: Lifeforce ($349/mo first month, $129/mo recurring + extras) — dedicated clinician + coach pair, quarterly labs, prescribing relationship. The right pick if you want a concierge longevity provider rather than just a diagnostic platform.
Skip if: you have no behavior-change plan tied to the data — lab numbers without protocol response are expensive curiosity. Without an intervention loop, even the best diagnostic platform is wasted spend.
Why annual comprehensive panels became the longevity default
Five years ago, getting a comprehensive 100+ marker biomarker panel meant either an executive-physical clinic charging $3,000-5,000 per visit or a sympathetic primary-care doctor willing to order the long list of advanced markers most insurance plans push back on. The longevity-medicine community had to bootstrap its own data infrastructure — spreadsheets, screenshots from the LabCorp portal, manual tracking across multiple ordering physicians. The data layer was real but the UX was terrible.
The 2026 landscape is genuinely different. Function Health productized the executive physical at $499/year with twice-yearly draws and AI-driven insights. Mito Health entered as the value-tier alternative at $359/year with past-lab integration. InsideTracker pivoted from athletes to the broader longevity audience with action-specific recommendations. Lifeforce built the concierge tier on top, bundling labs with coaching and prescribing. The result: a buyer in 2026 has four credible platforms to compare, all of them meaningfully better than the bootstrapped spreadsheet-and-PDF stack the longevity-medicine community ran on five years ago.
The consensus testing cadence has settled at 2x/year for most longevity buyers, with quarterly cadence becoming defensible for buyers running aggressive protocols (TRT, peptides, GLP-1s) where the intervention pace exceeds the biomarker shift timescale. That 2x/year frequency is built into the membership pricing of Function and Mito — not a coincidence. The cadence reflects what biomarkers actually do: most shift on weeks-to-months timescales, which makes monthly testing wasted spend and annual testing too coarse to catch protocol-driven changes.
The category has also matured on the panel-breadth side. The 110+ marker panels at Function and Mito go meaningfully deeper than standard primary-care panels (which typically stop at 20-25 markers). The depth matters in specific places: advanced lipid fractions (ApoB, Lp(a)) for cardiovascular risk stratification, comprehensive hormones for HRT-relevant tracking, autoimmune markers for inflammation-driven disease screening, heavy metals and toxin panels for environmental exposure assessment. Whether buyers actually need that depth depends on the protocol — most healthy 35-year-olds running a basic optimization stack will see most markers stay in range, with a small subset of meaningful signals to act on. The platforms exist to surface the signal above the noise.
Biomarker testing is a means, not an end
The hard truth about diagnostic platforms is that the data itself doesn’t change anything. A $359 Mito membership tells you your ApoB is 95 mg/dL. A $499 Function membership tells you the same number more thoroughly. Neither one moves the number. What moves the number is behavior change — dietary modification, statin therapy, exercise volume, sleep quality. The platforms are the measurement layer, not the intervention layer.
That sounds obvious, and yet most buyers don’t price it in. The math worth running before signing up: do you have a plan for what you’ll do with the data? If a marker comes back abnormal, do you have a clinician relationship who will help you act on it? Do you have the bandwidth and discipline to actually run the dietary, exercise, or supplement intervention the data suggests? If the answer to any of those is no, the platform is mostly an expensive form of curiosity, and the spend is better directed at the missing piece (a longevity clinician, a behavior-change coach, a structured intervention program) than at more diagnostic surface.
The four platforms in this guide differentiate partly on how much they support the intervention loop. InsideTracker leans heaviest into action specificity — every result comes with explicit food/exercise/supplement recommendations. Lifeforce bundles a dedicated clinician + coach pair so the intervention loop is built into the membership. Function and Mito sit in the middle: they do the data + AI insight layer well, but the intervention follow-through is on you (or on a separate clinician relationship like Marek Health for active prescribing). Pick the platform that matches the gap in your stack — if the missing piece is action specificity, InsideTracker. If the missing piece is the coaching loop, Lifeforce. If the missing piece is just the data layer and you have the rest of the stack already, Mito or Function.
The four contenders, compared
| Spec | Mito Health | Function Health | InsideTracker | Lifeforce |
|---|---|---|---|---|
| Annual cost | $359/yr | $499/yr | $589 single Ultimate | $349 first mo, then $129/mo + extras |
| Biomarkers tested | 100+ | 110+ | 48 (Ultimate) | ~50 |
| Cadence | 2x/year (annual membership) | 2x/year (included) | Single test or annual | Quarterly draws |
| Past-lab integration | Yes — upload historical bloodwork | No — own draws only | No | Limited |
| Physician access | MD review + consultations | Clinician review | No (algorithm-only) | Dedicated MD + health coach |
| AI insights | Personalized action plans | AI-driven insights + trends | Strongest action specificity | Concierge-led, not algorithm-led |
| Add-ons | Genetics, gut microbiome | Not currently offered | DNA add-on ($189) | Peptides, supplements, prescriptions |
| Editor's score | 8.6 / 10 | 8.7 / 10 | 8.2 / 10 | 8.0 / 10 (concierge tier) |
The four diagnostic platforms that actually deserve consideration
Mito Health — The value-tier comprehensive platform
$359/yr · 100+ biomarkers · Past-lab upload supported · AI-driven personalized action plans · Physician consultations included · Genetics + gut microbiome add-ons available
Mito Health entered the comprehensive-diagnostics market in 2023 with a clear positioning: same product surface as Function Health (100+ biomarkers, AI insights, physician review, longitudinal tracking), priced at $359/year vs Function’s $499. For buyers who’ve held off on Function specifically because of the price, Mito is the conservative-correct alternative. The $140 annual savings looks small in isolation — over five years it’s $700, enough to cover a Galleri test, a Prenuvo torso scan, or an extra year of TruDiagnostic epigenetic tracking.
The substantive differences vs Function are real and matter. Mito explicitly lets you upload past lab results so the AI insights work from day one — Function only tracks data drawn through its own service, which means your first year is partially educational rather than fully diagnostic. If you have a folder of bloodwork from your primary care, your previous TRT clinic, or a prior Function membership, that historical data feeds Mito’s trend visualization immediately. Mito also offers genetics and gut microbiome testing as paid add-ons, which Function does not currently cover. Whether those add-ons matter depends on your stack — most buyers won’t need them, but they exist for buyers building a deeper diagnostic surface.
Where Mito loses to Function is operational maturity. Mito is 2023-founded, vs Function’s 2022 launch with a much larger paid-acquisition footprint and deeper editorial coverage. The community size, peer-comparison data, and integration ecosystem all trail Function meaningfully. For buyers who weight track record and ecosystem depth, Function still wins. For first-time comprehensive-diagnostics buyers without prior platform commitment, Mito is the rational entry point.
Function Health — The category-defining membership
$499/yr · 110+ biomarkers · 2x/year draws included · AI-driven insights and trend visualization · Clinician review for abnormal markers · Quest Diagnostics partner network
Function Health is the platform that productized the executive physical. Pre-Function, getting a 110+ marker comprehensive panel meant either a $3,000-5,000 concierge clinic visit or a sympathetic primary-care doctor willing to order the long list of advanced markers. Function turned it into a $499/year membership with twice-yearly draws at the Quest Diagnostics network, AI-driven trend insights, and clinician review on anything abnormal. The proposition was right and the timing was right — the longevity-medicine community had been bootstrapping data infrastructure for years and Function was the first credible platform to package it cleanly.
What Function does well: the panel breadth (110+ markers including advanced lipid fractions, comprehensive hormones, heavy metals, autoimmune markers, cancer-relevant screens), the trend visualization (most primary-care portals don’t plot biomarker trajectories over time), the AI insight layer that explains what changed since last cycle in plain English, and the operational scale that makes Quest network draws accessible nationwide. The 4-year track record means the community size, peer-comparison data, and editorial coverage are all deeper than newer entrants.
Where Function loses ground in 2026: pricing pressure from Mito Health’s $359/year tier, no past-lab upload so your first year is partially educational rather than fully diagnostic, and no genetics or gut microbiome add-ons. For buyers already in Function’s ecosystem with longitudinal data, the migration cost rarely justifies the move — you’d be re-establishing your trend baseline. For new buyers comparing across the four platforms in this guide, the value math has shifted toward Mito unless ecosystem maturity matters specifically.
InsideTracker Ultimate — The action-specific data platform
$589 single Ultimate panel · 48 biomarkers · Algorithm-driven food / exercise / supplement recommendations · DNA add-on $189 · Lab draw or home kit · MIT-spinout science (founded 2009)
InsideTracker is the OG of “blood test plus AI advice.” The brand started in 2009 as MIT-spinout science applied to athlete bloodwork — fifteen years before Function Health existed. The Ultimate plan tests 48 biomarkers (vs Function’s 110+ and Mito’s 100+) but goes deeper on actionability: every result comes with specific food, exercise, and supplement recommendations tied to your individual numbers, plus DNA-informed adjustments if you add the genomics layer. Where Function and Mito tell you what your numbers are, InsideTracker tells you what to do about them.
The action specificity is the genuine differentiator. The recommendation engine maps individual biomarker values to a database of dietary and lifestyle interventions with published evidence behind them — if your ferritin is low, you get specific iron-rich foods plus supplementation guidance; if your cortisol is elevated, you get specific sleep and stress-management protocols; if your testosterone is mid-range, you get exercise volume and dietary recommendations targeting endogenous production. None of the other three platforms in this guide hit that level of “do X” specificity. Function and Mito surface the data and flag what changed; InsideTracker tells you the next step.
Where InsideTracker loses ground in 2026: the panel breadth caps at 48 markers, which is meaningfully narrower than Function’s 110+ or Mito’s 100+. For buyers wanting maximum biomarker coverage at the lowest annual cost, Function and Mito win on the math. The single-test pricing structure ($589 for Ultimate) also doesn’t scale as efficiently as the annual memberships if you’re running 2x/year cadence. The right buyer for InsideTracker is the one who values action specificity over biomarker breadth, doesn’t want to interpret raw lab data themselves, or wants the DNA-informed recommendation layer that Function and Mito don’t currently offer.
Lifeforce — The concierge longevity service
$349 first month, then $129/mo + medication and supplement add-ons · Quarterly draws · ~50 biomarkers · Dedicated MD + health coach pair · Prescribing relationship for hormones, peptides, GLP-1s · Tony Robbins-backed
Lifeforce is what Function Health would be if it tried to be your full longevity team instead of just your data layer. The membership bundles quarterly biomarker testing, a dedicated clinician + coach pair, and (when warranted) prescriptions — including hormone optimization, peptides, and longevity-targeted compounds. The pricing structure is the giveaway about who this is for: $349 first month then $129/mo recurring, plus add-ons for peptides ($150-400/mo each) and supplements. A serious member is spending $300-800/mo all-in once medication stacks. That’s not a gateway product — it’s a concierge service tier sitting alongside the diagnostic platforms in this guide rather than competing directly with them.
Where Lifeforce earns it: the clinician relationship is real, the coaching is meaningful for buyers who actually need accountability, and the integrated prescription flow saves you from cobbling together a peptide doctor + lab provider + supplement service yourself. For buyers who want a single concierge longevity provider — labs + coaching + prescriptions + accountability — the bundled model is genuinely valuable. The Tony Robbins-backed brand mostly attracts a specific buyer profile (high-touch coaching customers, not data-first optimizers), and the platform has invested heavily in the relationship layer that Function and Mito explicitly don’t offer.
Where Lifeforce doesn’t fit: data-first buyers who just want labs and trends should use Function or Mito for half to a third of the all-in cost. The biomarker breadth (~50 markers) is meaningfully narrower than Function’s 110+ or Mito’s 100+. The prescribing depth on hormones is shallower than Marek Health’s clinically aggressive multi-medication protocols. The right buyer for Lifeforce is the one who wants the bundled high-touch concierge model and budgets accordingly. The wrong buyer is the one comparing it head-to-head against Mito or Function on a per-biomarker-per-dollar basis.
Skip the category if…
- You need active prescription work for TRT or peptides. The platforms in this guide are diagnostic-only — they tell you what your numbers look like, but they don’t prescribe (Lifeforce is the partial exception, but its prescribing depth is shallow). For clinically aggressive TRT, multi-medication HRT protocols, HCG, anastrozole, enclomiphene, or peptides, use Marek Health for the depth or Hone Health for the entry-level monitored TRT use case. The right stack is one diagnostic platform paired with one prescribing platform, not one platform doing both poorly.
- You only need a single panel for one specific question. If you want to check thyroid because of an energy issue, or check hormones once to establish a baseline before deciding on TRT, the per-marker math doesn’t work for an annual subscription. Use Imaware’s à-la-carte panels — thyroid for $99, hormones for $199, comprehensive bundles $249-299 — with no membership commitment.
- You want pathology screening, not biomarker tracking. The platforms in this guide measure blood chemistry over time. They don’t screen for cancer, structural anomalies, or imaging-detectable disease. For that layer of the longevity stack, use Galleri ($949 multi-cancer early detection blood test) or Prenuvo ($999-2,499 whole-body MRI). The full longevity diagnostic stack for buyers with budget includes both — a biomarker membership plus an annual screening test, not one or the other.
- You want biological-age tracking, not biomarker tracking. Epigenetic age testing is a different category. For longitudinal pace-of-aging data, use TruDiagnostic’s TruAge — single test $229-299, COMPLETE subscription $499-799/yr with quarterly retests across DunedinPACE, Horvath, OMICmAge, and other validated clocks. Pair with one of the platforms in this guide for the full diagnostic surface.
- You don’t have a behavior-change plan tied to the data. Lab numbers without protocol response are expensive curiosity. If you don’t have a clinician relationship, a behavior-change plan, or the bandwidth to act on what the platform surfaces, the spend is better directed at the missing piece (a longevity clinician, a coaching service, a structured intervention program) than at more diagnostic surface. Build the intervention loop first, then add the data layer.
- You’re cost-anchored to insurance-covered primary care. If you’re unwilling to spend $359-499/year out of pocket for comprehensive longevity bloodwork, the right move is to maximize what your primary care will order under insurance — advanced lipid fractions (ApoB, Lp(a)), comprehensive metabolic panels, hormones if symptomatic, hs-CRP for inflammation — and skip the platform layer entirely. Spreadsheet-based tracking is worse UX but does deliver the same underlying data at no cash cost.
The decision framework
Three questions decide the right diagnostic platform for most buyers:
- Data layer or full service? If you want the data + AI insight layer and have the rest of your stack already (clinician relationship, intervention plan, behavior-change discipline), pick Mito Health or Function Health. If you want a single concierge provider that bundles labs + coaching + prescriptions + accountability into one membership, pick Lifeforce and budget $300-800/mo all-in. These are different categories, not different points on a price curve.
- Mito or Function? If you have past lab results to upload, Mito Health wins on day-one utility and saves $140/year. If you want the most established ecosystem, larger community, and 4-year operational track record, Function Health wins. For most first-time buyers without prior platform commitment, Mito is the rational entry point. For buyers already in Function’s ecosystem, the migration cost rarely justifies the move.
- Biomarker breadth or action specificity? If you want maximum biomarker coverage at the lowest annual cost, Function (110+) and Mito (100+) win on the math. If you want the strongest “do X” recommendations tied to your results — specific food, exercise, and supplement actions rather than raw lab data — InsideTracker’s 48-marker Ultimate panel ($589 single test) is the action-layer pick. Buyers comfortable interpreting their own lab data should optimize for breadth; buyers wanting the platform to tell them what to do should optimize for InsideTracker’s recommendation engine.
If you’re a first-time comprehensive-diagnostics buyer in 2026, buy Mito Health at $359/year for 100+ biomarkers, past-lab integration, and AI-driven personalized insights. If you weight ecosystem maturity over the $140 annual savings, Function Health at $499/year is the defensible alternative. If you want the strongest action-specific recommendations rather than raw biomarker breadth, InsideTracker Ultimate at $589 single test is the right call. If you want a concierge longevity provider that bundles labs + coaching + prescriptions, Lifeforce at $129/mo recurring (plus extras) sits in a different category and is the right pick for buyers who want the high-touch model and budget for it. Pair any of these with a single-vertical prescriber like Marek Health for active TRT or peptide protocols, and an annual screening test (Galleri or Prenuvo) for the pathology layer your biomarker membership doesn’t cover. See our best NMN supplements and best longevity wearables guides for the surrounding stack.
Diagnostic platform buyer's questions
How often should I run lab work?
The consensus longevity-medicine cadence is 2x/year for comprehensive panels. Most premium platforms in this guide are built around that frequency — Function Health includes two annual draws in its $499 membership, Mito Health structures its annual cadence around the same rhythm, and Lifeforce runs quarterly for its concierge tier. The 2x/year cadence balances signal vs noise: most biomarkers shift slowly enough that monthly testing is wasted spend, while annual testing misses meaningful protocol-driven changes. For buyers running aggressive interventions (TRT, peptides, GLP-1s), quarterly cadence becomes defensible. For buyers maintaining a baseline, twice a year is the right answer.
Function vs Mito — which to pick?
Function Health and Mito Health share roughly the same product surface — 100+ biomarkers, AI insights, physician review, longitudinal tracking — at different price points. Function is $499/year and has a 4-year head start on operational track record, larger community, deeper editorial coverage, and more mature integrations. Mito is $359/year (a $140 annual savings), explicitly supports past-lab uploads so the AI insights work from day one, and offers genetics + gut microbiome as paid add-ons that Function does not currently cover. For first-time comprehensive-diagnostics buyers, Mito is the rational entry point. For buyers already in Function's ecosystem with longitudinal data, the migration cost is real and the savings rarely justify the move. Pick one and commit — running both is wasted spend.
Are these covered by insurance?
Generally no, but the math is more nuanced than that. Function Health, Mito Health, InsideTracker, and Lifeforce all operate cash-pay outside the insurance system. Some buyers can run individual marker tests through their primary care covered by insurance, then layer the platform memberships on top for the AI insights and trend visualization. HSA/FSA reimbursement is sometimes available depending on plan — Function and Mito both publish FSA-eligibility guidance for buyers running through Truemed-style medical-necessity processes. The honest framing: these are out-of-pocket longevity-medicine spending, not medically-billed care, and the value proposition is the data layer + AI + cadence rather than insurance arbitrage.
Is at-home blood draw accurate?
Yes, with caveats. The platforms in this guide all run their lab work through CLIA-certified facilities (Quest, LabCorp, or partner labs), which means the analytical quality of the result is identical to what you'd get at a clinic draw. The variable is the pre-analytical phase — sample collection, handling, and shipping. At-home dried blood spot kits work well for most biomarkers but underperform on a small subset (some hormones, some lipid fractions) where venous draw is the gold standard. Function and Mito both default to in-person Quest/LabCorp draws for their comprehensive panels, which keeps the pre-analytical variable controlled. InsideTracker offers both lab draw and home kit options. The pragmatic frame: for the 100+ marker comprehensive panels, you'll be doing in-person draws; the at-home convenience is more relevant for single-panel à la carte testing.
What about Galleri or Prenuvo?
Galleri (multi-cancer early detection blood test, $949) and Prenuvo (whole-body MRI, $999-2,499) are different products solving different problems. The platforms in this guide are biomarker-tracking memberships — they tell you what your blood chemistry looks like over time. Galleri and Prenuvo are screening tests — they look for specific pathology (cancer, structural anomalies) at a single point in time. The right longevity stack for buyers with budget includes both: a comprehensive biomarker membership (Mito or Function) for the longitudinal data, plus an annual or biannual screening test (Galleri for cancer signal, Prenuvo for imaging) for the pathology layer. They are complements, not substitutes.
Do I need a doctor's order?
No for the platforms in this guide — Mito, Function, InsideTracker, and Lifeforce all handle the physician order on their side as part of the membership. The platforms employ physicians who issue the lab requisitions, and you book the draw at a partner network (Quest, LabCorp, or in-home phlebotomy depending on platform). Galleri is the exception — it requires a physician order separately, which Galleri's telehealth partner can handle, but it adds a step. For buyers who already have a longevity clinician, you can sometimes order the same panels through your physician at lower per-marker cost; the platforms are paying for the AI insights, trend visualization, and cadence convenience on top of the raw lab data.
What if I'm on TRT or peptides?
The platforms in this guide are diagnostic-only — they tell you what your numbers look like, but they don't prescribe. If you're on TRT, peptides, or GLP-1s, you need a separate prescribing relationship: Marek Health for clinically aggressive TRT and ancillaries, Hone Health for entry-level monitored TRT, Maximus for enclomiphene + GLP-1 protocols, or a clinic-based provider like Defy Medical. The pragmatic stack is to pair one diagnostic platform (Mito or Function for biomarker breadth, InsideTracker for actionable specificity) with one prescribing platform that matches your protocol complexity. Lifeforce is the partial exception — it bundles labs + coaching + prescriptions in one concierge tier, but the all-in monthly cost ($300-800) reflects the bundled scope, and the prescribing depth is shallower than Marek's.
How long until I see results in my numbers?
Most biomarkers shift on weeks-to-months timescales rather than days. Lipid panels (LDL, HDL, triglycerides) respond to dietary and statin changes within 4-8 weeks. Glucose and insulin sensitivity markers (HbA1c, fasting insulin) shift on 8-12 week timescales because HbA1c reflects 90-day average glycation. Hormones (testosterone, estradiol, cortisol) respond to TRT or behavioral changes within 4-12 weeks depending on the marker. Inflammatory markers (hs-CRP, ferritin) can shift faster, sometimes within 2-4 weeks of significant interventions. The pragmatic frame: don't expect to see meaningful protocol-driven shifts on the cycle right after starting a new intervention. The 6-month cadence built into Mito and Function memberships exists because that's when the trend signal actually becomes interpretable above the noise floor.
Can I just use my primary care doctor?
For comprehensive longevity bloodwork, almost always no. Standard primary-care panels stop at roughly 20-25 markers — basic lipid, basic metabolic, CBC, maybe a TSH. The platforms in this guide test 48-110+ markers including advanced lipid fractions (ApoB, Lp(a)), comprehensive hormones, autoimmune markers, heavy metals, advanced inflammation panels, and longevity-relevant biomarkers most primary-care providers don't order. Beyond panel breadth, the trend visualization, AI insights, and longitudinal tracking are what most primary-care portals don't offer. The honest framing: keep your primary-care relationship for medical care, use one of these platforms for the longevity-medicine data layer. They serve different functions and the right answer is to use both.
Why is Lifeforce so much more expensive?
Lifeforce is a different product category. Mito ($359/yr), Function ($499/yr), and InsideTracker ($589 single Ultimate) are diagnostic platforms — they sell biomarker data with insights on top. Lifeforce ($349 first month then $129/mo recurring, plus medication and supplement add-ons) is a concierge longevity service — you get a dedicated clinician + coach pair, prescribing relationship, and ongoing protocol management. A serious Lifeforce member spends $300-800/mo all-in once medication and supplements stack. For data-first buyers who just want labs and trends, Function or Mito at half the price is the right answer. For buyers who want a single concierge longevity provider — labs + coaching + prescriptions + accountability — Lifeforce is priced where the service tier sits, not where the diagnostic tier sits.
Build the surrounding longevity stack
A diagnostic platform is one layer of a broader longevity stack. The other high-conviction layers most serious buyers run alongside biomarker tracking:
- Best NMN supplements 2026 — Wonderfeel, Renue by Science, Genuine Purity, and the Tru Niagen NR alternative.
- Best cold plunges 2026 — Plunge Pro, Renu, Edge, Inergize, Ice Barrel head-to-head.
- Best longevity wearables 2026 — Oura, WHOOP, Ultrahuman, Apple Watch, Garmin compared.
- Best infrared saunas 2026 — the hot-side complement to cold plunge.
- Best red light therapy panels 2026 — photobiomodulation hardware shortlist.
- Best sleep tech 2026 — mattresses, climate control, and sleep-stage tooling.
This guide was researched and written by the editorial team at Lifespan Vault, sister publication to MyProtocolStack. Platform specs, pricing, biomarker counts, cadence, and add-on availability were verified against manufacturer pages on 2026-05-05. Pricing is dated and may shift; we update verified-at dates on individual product pages quarterly. Lifespan Vault may earn affiliate commission on outbound product links — Mito Health is the only platform in this guide where we currently have an affiliate relationship (via Awin). Function Health, InsideTracker, and Lifeforce are listed for editorial completeness with direct links and no commission. Rankings and editorial coverage are not for sale, and disclosures appear on every product page. For our full review process, see methodology / test protocol.